Evidence map›Paper›PMID 25851587›Full record

ArticleNature communications2015

A cohesin-OCT4 complex mediates Sox enhancers to prime an early embryonic lineage.

Nesrine Abboud, Thomas Moore- Morris, Emilye Hiriart, Henry Yang, Hudson Bezerra, Maria-Giovanna Gualazzi, Sonia Stefanovic, Anne-Claire Guénantin, Sylvia M Evans, Michel Pucéat

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 32 citations in OpenAlex.

  1. SOX17 in pulmonary arterial hypertension: from development to clinical phenotype.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  2. Article
  3. Liquid condensates: a new barrier to loop extrusion?Cellular and molecular life sciences : CMLS · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Nesrine AbboudINSERM UMR 633, Genopole Evry, University Paris Descartes, 91000 Evry, Paris, France.
Thomas Moore- MorrisINSERM UMR 910, GMGF, Aix-Marseille University, 13885 Marseille, France.
Emilye HiriartINSERM UMR 633, Genopole Evry, University Paris Descartes, 91000 Evry, Paris, France.
Henry YangCancer Science Institute, National University of Singapore, Singapore 138672, Singapore.
Hudson BezerraINSERM UMR 633, Genopole Evry, University Paris Descartes, 91000 Evry, Paris, France.
Maria-Giovanna GualazziINSERM UMR 633, Genopole Evry, University Paris Descartes, 91000 Evry, Paris, France.
Sonia StefanovicINSERM UMR 633, Genopole Evry, University Paris Descartes, 91000 Evry, Paris, France.
Anne-Claire GuénantinINSERM UMR 633, Genopole Evry, University Paris Descartes, 91000 Evry, Paris, France.
Sylvia M EvansSkaggs School of Pharmacy and Pharmaceutical Sciences, Department of Medecine and Department of Pharmacology, UCSD, La Jolla, California 92093, California, USA.
Michel PucéatINSERM UMR 633, Genopole Evry, University Paris Descartes, 91000 Evry, Paris, France.
Aix-Marseille Université · FRGenopole (France) · FR

Funding

Developmental Regulatory Genomics of Human Cardiovascular LineagesUM1HL128773 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHI, NEIL C, EVANS, SYLVIA M · 2015 to 2019
$3.8M
NHLBI NIH HHS UM1 HL128773
6 · The paper itself

Abstract

Short- and long-scales intra- and inter-chromosomal interactions are linked to gene transcription, but the molecular events underlying these structures and how they affect cell fate decision during embryonic development are poorly understood. One of the first embryonic cell fate decisions (that is, mesendoderm determination) is driven by the POU factor OCT4, acting in concert with the high-mobility group genes Sox-2 and Sox-17. Here we report a chromatin-remodelling mechanism and enhancer function that mediate cell fate switching. OCT4 alters the higher-order chromatin structure at both Sox-2 and Sox-17 loci. OCT4 titrates out cohesin and switches the Sox-17 enhancer from a locked (within an inter-chromosomal Sox-2 enhancer/CCCTC-binding factor CTCF/cohesin loop) to an active (within an intra-chromosomal Sox-17 promoter/enhancer/cohesin loop) state. SALL4 concomitantly mobilizes the polycomb complexes at the Soxs loci. Thus, OCT4/SALL4-driven cohesin- and polycombs-mediated changes in higher-order chromatin structure mediate instruction of early cell fate in embryonic cells.

Indexed as

AnimalsBasic Helix-Loop-Helix ProteinsCCCTC-Binding FactorCell Cycle ProteinsChromatin ImmunoprecipitationChromosomal Proteins, Non-HistoneCohesinsDNA-Binding ProteinsEmbryo, MammalianEmbryonic Stem CellsGene Expression Regulation, DevelopmentalGene Knockdown TechniquesGreen Fluorescent ProteinsHeartHMGB ProteinsHuman Embryonic Stem CellsBasic Helix-Loop-Helix ProteinsBMI1 protein, humanCCCTC-Binding FactorCell Cycle ProteinsChromosomal Proteins, Non-HistoneCohesinsCTCF protein, humanCtcf protein, mouseDNA-Binding ProteinsGreen Fluorescent ProteinsHMGB ProteinsMesp1 protein, mouseNeoplasm ProteinsOctamer Transcription Factor-3Polycomb-Group ProteinsPolycomb Repressive Complex 1Polycomb Repressive Complex 2POU5F1 protein, humanPou5f1 protein, mouseRepressor ProteinsSALL4 protein, humanSall4 protein, mouseSox17 protein, mouseSox2 protein, mouseSOXB1 Transcription FactorsSOXF Transcription FactorsSOX Transcription FactorsSUZ12 protein, humanTranscription Factors

Identifiers

PMID25851587
PMCPMC5531045
OpenAlexW2094448916

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.